Shanghai United Imaging Healthcare Co., Ltd. (SHA:688271)

China · Delayed Price · Currency is CNY

115.52

-0.98 (-0.84%)

Jul 31, 2026, 3:00 PM CST

SHA:688271 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	14,230	13,800	10,300	11,411	9,238	7,254
Revenue Growth	36.46%	33.98%	-9.73%	23.52%	27.36%	25.91%
Gross Profit	6,614	6,480	5,006	5,328	4,394	3,561
Operating Income	1,927	1,826	959.42	1,654	1,453	1,389
Net Income	1,898	1,869	1,262	1,974	1,656	1,417
Earnings Per Share	2.31	2.28	1.54	2.40	2.19	1.96
EPS Growth	48.99%	48.05%	-35.83%	9.59%	11.73%	50.93%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	10,369
Overseas	3,431
Total	13,800

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8,920	10,429	10,106	12,504	14,097	3,254
Total Debt	1,629	1,250	684.68	155.93	134.45	153.94
Net Cash (Debt)	7,292	9,179	9,421	12,348	13,963	3,100
Net Cash Growth	-13.44%	-2.57%	-23.70%	-11.57%	350.45%	18.84%
Net Cash Per Share	8.87	11.20	11.50	15.01	18.46	4.29

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	2,073	2,679	-619.02	132.51	682.81	942.45
Capital Expenditures	-2,311	-2,093	-1,946	-1,076	-741.34	-346.74
Free Cash Flow	-237.35	585.84	-2,565	-943.31	-58.52	595.72
Free Cash Flow Growth	-	-	-	-	-	-77.15%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	46.48%	46.96%	48.60%	46.70%	47.56%	49.09%
Operating Margin	13.54%	13.23%	9.31%	14.49%	15.73%	19.14%
Pretax Margin	14.51%	14.36%	13.12%	18.77%	20.78%	23.40%
Profit Margin	13.34%	13.54%	12.25%	17.30%	17.93%	19.54%
FCF Margin	-1.67%	4.25%	-24.90%	-8.27%	-0.63%	8.21%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.310	0.310	0.200	0.250	0.201
Dividend Per Share Growth	-14.29%	55.00%	-20.00%	24.38%	-
Dividend Yield	0.27%	0.25%	0.16%	0.18%	0.11%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	50.03	55.05	82.03	57.19	88.08	-
Forward PE	44.57	49.88	50.26	60.36	68.86	-
P/FCF Ratio	-	175.67	-	-	-	-
PS Ratio	6.66	7.46	10.05	9.90	15.79	-